The Food and Drug Administration today issued guidance implementing section 3121 of the Coronavirus Aid, Relief, and Economic Security Act, which requires manufacturers to notify FDA of a permanent discontinuance or significant interruption in the manufacture of certain medical devices to prevent or mitigate shortages during the COVID-19 emergency.

FDA said the guidance aims to clarify and make recommendations regarding who must notify FDA and how, and what information to include in the notification.

Related News Articles

Headline
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-15 year olds more than four months after the second dose in…
Headline
The Department of Health and Human Services today began distributing $7.5 billion of the $8.5 billion in American Rescue Plan Act payments designated for…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., Friday expanded eligibility for COVID-19 booster shots to include all adults…
Headline
The Health Resources and Services Administration in September gave health care providers who received more than $10,000 in Provider Relief Funds between April…
Headline
The AHA, American Medical Association and American Nurses Association today released a television and digital ad in English and Spanish thanking…
Headline
Vice President Kamala Harris today expects to announce $1.5 billion in American Rescue Plan Act funding for the National Health Service Corps, Nurse Corps…